Literature DB >> 20204354

Measurement of coronary flow reserve by noninvasive cardiac imaging.

Alberto Cuocolo, Mario Petretta, Andrea Soricelli.   

Abstract

Mesh:

Year:  2010        PMID: 20204354     DOI: 10.1007/s00259-010-1401-9

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  52 in total

1.  Myocardial flow reserve parametric map, assessed by first-pass MRI compartmental analysis at the chronic stage of infarction.

Authors:  P Germain; G Roul; J Baruthio; C Jahn; P M Coulbois; B Dumitresco; J L Dietemann; P Bareiss; A Constantinesco
Journal:  J Magn Reson Imaging       Date:  2001-03       Impact factor: 4.813

Review 2.  REVIEW OF PREVIOUS STUDIES AND CURRENT THEORIES OF AUTOREGULATION.

Authors:  P C JOHNSON
Journal:  Circ Res       Date:  1964-08       Impact factor: 17.367

3.  The safety of deFinity and Optison for ultrasound image enhancement: a retrospective analysis of 78,383 administered contrast doses.

Authors:  Kevin Wei; Sharon L Mulvagh; Lisa Carson; Ravin Davidoff; Ruvin Gabriel; Richard A Grimm; Stephanie Wilson; Lorrie Fane; Charles A Herzog; William A Zoghbi; Rhonda Taylor; Michael Farrar; Farooq A Chaudhry; Thomas R Porter; Waleed Irani; Roberto M Lang
Journal:  J Am Soc Echocardiogr       Date:  2008-10-10       Impact factor: 5.251

4.  Estimation of coronary flow reserve by Tc-99m sestamibi imaging in patients with coronary artery disease: comparison with the results of intracoronary Doppler technique.

Authors:  Giovanni Storto; Plinio Cirillo; Maria Lucia Eufrasia Vicario; Teresa Pellegrino; Anna Rita Sorrentino; Mario Petretta; Gennaro Galasso; Valerio De Sanctis; Federico Piscione; Alberto Cuocolo
Journal:  J Nucl Cardiol       Date:  2004 Nov-Dec       Impact factor: 5.952

5.  Estimation of coronary flow reserve with the use of dynamic planar and SPECT images of Tc-99m tetrofosmin.

Authors:  H Sugihara; Y Yonekura; K Kataoka; D Fukai; N Kitamura; Y Taniguchi
Journal:  J Nucl Cardiol       Date:  2001 Sep-Oct       Impact factor: 5.952

Review 6.  Role of positron emission tomography in the investigation of human coronary circulatory function.

Authors:  R de Silva; P G Camici
Journal:  Cardiovasc Res       Date:  1994-11       Impact factor: 10.787

7.  Optimization of flow reserve measurement using SPECT technology to evaluate the determinants of coronary microvascular dysfunction in diabetes.

Authors:  Cecilia Marini; GianPaolo Bezante; Patrizia Gandolfo; Elisa Modonesi; Silvia D Morbelli; Angelo Depascale; Daniela Rollando; Davide Maggi; Manuela Albertelli; Riccardo Armonino; Manrico Balbi; Claudio Brunelli; Renzo Cordera; Gianmario Sambuceti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-12-03       Impact factor: 9.236

8.  Insulin induced increase in coronary flow reserve is abolished by dexamethasone in young men with uncomplicated type 1 diabetes.

Authors:  H Laine; J Sundell; P Nuutila; O T Raitakari; M Luotolahti; T Rönnemaa; T Elomaa; P Koskinen; J Knuuti
Journal:  Heart       Date:  2004-03       Impact factor: 5.994

9.  Transstenotic coronary pressure gradient measurement in humans: in vitro and in vivo evaluation of a new pressure monitoring angioplasty guide wire.

Authors:  B De Bruyne; N H Pijls; W J Paulus; P J Vantrimpont; S U Sys; G R Heyndrickx
Journal:  J Am Coll Cardiol       Date:  1993-07       Impact factor: 24.094

Review 10.  Biological effects of exposure to magnetic resonance imaging: an overview.

Authors:  Domenico Formica; Sergio Silvestri
Journal:  Biomed Eng Online       Date:  2004-04-22       Impact factor: 2.819

View more
  2 in total

1.  New SPECT technology: potential and challenges.

Authors:  Brian F Hutton
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-10       Impact factor: 9.236

2.  Target heart rate to determine the normal value of coronary flow reserve during dobutamine stress echocardiography.

Authors:  Ezequiel H Forte; Maria G Rousse; Jorge A Lowenstein
Journal:  Cardiovasc Ultrasound       Date:  2011-04-04       Impact factor: 2.062

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.